Schrödinger, Inc. (SDGR)

Market Cap	1.78B
Revenue (ttm)	180.96M
Net Income (ttm)	-149.19M
Shares Out	71.49M
EPS (ttm)	-2.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	58,858
Open	24.91
Previous Close	24.63
Day's Range	24.81 - 25.29
52-Week Range	15.85 - 36.33
Beta	1.02
Analysts	Buy
Price Target	52.40 (+109.81%)
Earnings Date	May 2, 2023

About SDGR

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. T...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Feb 6, 2020
• Employees: 664
• Stock Exchange: NASDAQ
• Ticker Symbol: SDGR

Financial Performance

In 2022, Schrodinger's revenue was $180.96 million, an increase of 31.19% compared to the previous year's $137.93 million. Losses were -$149.19 million, 48.6% more than in 2021.

Analyst Forecast

According to 15 analysts, the average rating for SDGR stock is "Buy." The 12-month stock price forecast is $52.4, which is an increase of 109.81% from the latest price.

Price Target

$52.4

(109.81% upside)

Analyst Consensus: Buy